142 related articles for article (PubMed ID: 11036962)
1. Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice.
Louvet C; Coudray AM; Tournigand C; Prévost S; Raymond E; de Gramont A; Chazard M; Gespach C
Anticancer Drugs; 2000 Aug; 11(7):579-82. PubMed ID: 11036962
[TBL] [Abstract][Full Text] [Related]
2. Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study.
Sheikh HY; Valle JW; Palmer K; Sjursen A; Craven O; Wilson G; Swindell R; Saunders MP
Br J Cancer; 2007 Jan; 96(1):38-43. PubMed ID: 17213824
[TBL] [Abstract][Full Text] [Related]
3. Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study.
Francois E; Smith D; Dahan L; Michel C; Perrier H; Mari V; Seitz JF; Follana P; Evesque L; Chamorey E
J Chemother; 2012 Aug; 24(4):207-11. PubMed ID: 23040684
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin and UFT/oral calcium folinate for advanced colorectal carcinoma.
Hoff PM; Pazdur R
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):48-50. PubMed ID: 10442361
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
6. Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer Xenografts.
Nagase H; Nakagawa F; Uchida J
Chemotherapy; 2018; 63(1):46-52. PubMed ID: 29393100
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Meropol NJ; Sonnichsen DS; Birkhofer MJ; Ferreira I; Noel D
Cancer Chemother Pharmacol; 1999; 43(3):221-6. PubMed ID: 9923552
[TBL] [Abstract][Full Text] [Related]
8. Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer.
Kusumoto T; Sunami E; Ota M; Yoshida K; Sakamoto Y; Tomita N; Maeda A; Mochizuki I; Okabe M; Kunieda K; Yamauchi J; Itabashi M; Kotake K; Takahashi K; Baba H; Boku N; Aiba K; Ishiguro M; Morita S; Sugihara K
Clin Colorectal Cancer; 2018 Jun; 17(2):e153-e161. PubMed ID: 29249584
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase II study of tegafur-uracil/leucovorin versus tegafur-uracil/leucovorin plus oxaliplatin after curative resection of high-risk stage II/III colorectal cancer (SOAC-1101 trial).
Kosugi C; Koda K; Takiguchi N; Takaishi S; Miyauchi H; Hirayama N; Nomura Y; Kondo E; Kawasaki Y; Ozawa Y; Matsubara H
Int J Colorectal Dis; 2021 Aug; 36(8):1739-1749. PubMed ID: 33715077
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Nukatsuka M; Nakagawa F; Takechi T
Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
[TBL] [Abstract][Full Text] [Related]
11. A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada.
Maroun J; Asche C; Romeyer F; Mukherjee J; Cripps C; Oza A; Skillings J; Letarte J
Pharmacoeconomics; 2003; 21(14):1039-51. PubMed ID: 13129416
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
Hasegawa K; Saiura A; Takayama T; Miyagawa S; Yamamoto J; Ijichi M; Teruya M; Yoshimi F; Kawasaki S; Koyama H; Oba M; Takahashi M; Mizunuma N; Matsuyama Y; Watanabe T; Makuuchi M; Kokudo N
PLoS One; 2016; 11(9):e0162400. PubMed ID: 27588959
[TBL] [Abstract][Full Text] [Related]
13. Antitumor efficacy of combination chemotherapy with UFT and cyclophosphamide against human breast cancer xenografts in nude mice.
Haga S; Shimizu T; Imamura H; Watanabe O; Kinoshita J; Fukushima M; Kajiwara T
Anticancer Res; 1999; 19(3A):1791-6. PubMed ID: 10470117
[TBL] [Abstract][Full Text] [Related]
14. [Systemic treatment of colorectal cancers--factual standards and perspectives].
Miron L
Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):752-8. PubMed ID: 14756014
[TBL] [Abstract][Full Text] [Related]
15. [Effect of calmodulin antagonists (W-5 and W-7) on antitumor activity of Tegafur and UFT (Tegafur plus uracil)].
Kikuchi Y; Oomori K; Iwano I; Kizawa I; Miyauchi M; Kita T; Kato K
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):422-8. PubMed ID: 3131462
[TBL] [Abstract][Full Text] [Related]
16. UFT modulated with leucovorin in advanced colorectal cancer: Oncopaz experience.
González Barón M; Feliu J; Garcia Girón C; Espinosa J; Martinez B; Blanco E; Crespo MC; Ordóñez A; Espinosa E; de Castro J; Juárez F; Colmenarejo A
Oncology; 1997; 54 Suppl 1():24-9. PubMed ID: 8978581
[TBL] [Abstract][Full Text] [Related]
17. The role of additional chemotherapy with oral UFT in intravenous combination chemotherapy with cisplatin and 5-fluorouracil for human gastric cancer xenograft lines of well- and poorly- differentiated adenocarcinomas transplanted in nude mice.
Tseng CC; Nio Y; Tsubono M; Kawabata K; Masai Y; Hayashi H; Fukumoto M; Tobe T
Anticancer Res; 1992; 12(4):1295-9. PubMed ID: 1503424
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients.
Rosati G; Cordio S; Tucci A; Blanco G; Bordonaro R; Reggiardo G; Manzione L
Oncology; 2005; 69(2):122-9. PubMed ID: 16118508
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.
Pazdur R; Lassere Y; Rhodes V; Ajani JA; Sugarman SM; Patt YZ; Jones DV; Markowitz AB; Abbruzzese JL; Bready B
J Clin Oncol; 1994 Nov; 12(11):2296-300. PubMed ID: 7964943
[TBL] [Abstract][Full Text] [Related]
20. Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer.
Méndez M; Alfonso PG; Pujol E; González E; Castañon C; Cerezuela P; López-Mateos Y; Cruz JJ
Invest New Drugs; 2005 Jun; 23(3):243-51. PubMed ID: 15868381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
